Subtopic Deep Dive
HLA-B*5801 Association with Allopurinol Hypersensitivity
Research Guide
What is HLA-B*5801 Association with Allopurinol Hypersensitivity?
HLA-B*58:01 allele strongly associates with allopurinol-induced severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in high-risk populations.
Prospective HLA-B*58:01 genotyping before allopurinol therapy reduced SCAR incidence from 0.35% to 0% in Taiwan (Ko et al., 2015, 197 citations). Meta-analysis of 21 studies confirmed the allele's role across populations (Wu et al., 2016, 39 citations). Cost-effectiveness of genotyping supports routine screening in gout patients (Ke et al., 2017, 61 citations).
Why It Matters
HLA-B*58:01 screening prevents life-threatening SCARs in hyperuricemia patients, as shown by Ko et al. (2015) national cohort reducing incidence through alternative therapies. Ke et al. (2017) demonstrated genotyping's cost-effectiveness, saving healthcare costs in Asian populations. Wu et al. (2016) meta-analysis guides global risk stratification, influencing guidelines like American College of Rheumatology recommendations (Nguyen et al., 2016).
Key Research Challenges
Population-Specific Risk Variation
HLA-B*58:01 prevalence and odds ratios differ across ethnicities, complicating universal guidelines (Wu et al., 2016). Kinh Vietnamese case-control identified additional risk factors beyond HLA (Duc et al., 2020). Validation studies needed for non-Asian groups (Jurado-Escobar et al., 2017).
Genotyping Cost-Effectiveness
Balancing screening costs against SCAR prevention remains debated despite favorable models (Ke et al., 2017). Rapid, inexpensive methods require broader validation (Nguyen et al., 2016). Integration into clinical workflows challenges resource-limited settings.
Alternative Therapy Implementation
Carrier identification demands effective non-allopurinol options for gout management. Prospective studies show feasibility but real-world adherence lags (Ko et al., 2015). Long-term outcomes post-genotyping need tracking (Verma et al., 2013).
Essential Papers
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
Tai-Ming Ko, Chang‐Youh Tsai, Shih-Yang Chen et al. · 2015 · BMJ · 197 citations
Prospective screening of the HLA-B*58:01 allele, coupled with an alternative drug treatment for carriers, significantly decreased the incidence of allopurinol induced SCARs in Taiwanese medical cen...
Severe cutaneous adverse drug reactions
Rajesh Verma, Biju Vasudevan, Vijendran Pragasam · 2013 · Medical Journal Armed Forces India · 81 citations
Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
Ching-Hua Ke, Wen‐Hung Chung, Yen-Hsia Wen et al. · 2017 · The Journal of Rheumatology · 61 citations
Objective. Patients with an HLA-B*58:01 allele have an increased risk of developing severe cutaneous adverse drug reactions (SCAR) when treated with allopurinol. Although one-off pharmacogenetic te...
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus
Gökhan Okan, Serpil Yaylacı, Önder Peker et al. · 2008 · World Journal of Gastroenterology · 43 citations
Stevens-Johnson syndrome (SJS) is a serious and potentially life-threatening disease. Vanishing bile duct syndrome (VBDS) is a rare cause of progressive cholestasis. Both syndromes are mostly relat...
Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
Ruiyang Wu, Yiju Cheng, Li Zhu et al. · 2016 · Oncotarget · 39 citations
Allopurinol is widely used for hyperuricemia and gouty arthritis, but is associated with cutaneous adverse drug reactions (CADRs). Recently, HLA-B*58:01 allele was identified as a strong genetic ma...
Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: results from a case-control study
Duc M, Thao Phuong, Anh Duy et al. · 2020 · Arthritis Research & Therapy · 26 citations
Update on the Genetic Basis of Drug Hypersensitivity Reactions
Raquel Jurado‐Escobar, James R. Perkins, Elena Garcı́a-Martı́n et al. · 2017 · Journal of Investigational Allergology and Clinical Immunology · 22 citations
Drug hypersensitivity reactions (DHRs) are unpredictable, complex responses to medicines in predisposed individuals. They represent a major health problem owing to the number of patients affected a...
Reading Guide
Foundational Papers
Start with Verma et al. (2013, 81 citations) for SCAR overview, then Ko et al. (2015, 197 citations) for genotyping impact evidence.
Recent Advances
Wu et al. (2016) meta-analysis; Duc et al. (2020) Vietnamese risks; Ke et al. (2017) economics.
Core Methods
HLA genotyping (PCR, sequencing per Nguyen et al., 2016); prospective cohort screening (Ko et al., 2015); meta-analysis (Wu et al., 2016); case-control (Duc et al., 2020).
How PapersFlow Helps You Research HLA-B*5801 Association with Allopurinol Hypersensitivity
Discover & Search
Research Agent uses searchPapers and exaSearch to find Ko et al. (2015) Taiwan cohort (197 citations), then citationGraph reveals Wu et al. (2016) meta-analysis and 20 related pharmacogenetic studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Ke et al. (2017), runs runPythonAnalysis to extract and plot HLA-B*58:01 odds ratios from meta-data using pandas, with verifyResponse (CoVe) and GRADE grading confirming high-quality evidence for cost-effectiveness.
Synthesize & Write
Synthesis Agent detects gaps in non-Asian validation via gap detection, flags contradictions between population studies; Writing Agent uses latexEditText, latexSyncCitations for Ko et al. (2015) and Wu et al. (2016), latexCompile for risk stratification review, exportMermaid for allele prevalence diagrams.
Use Cases
"Extract odds ratios for HLA-B*58:01 from allopurinol SCAR meta-analyses and plot confidence intervals"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Wu et al., 2016) → runPythonAnalysis (pandas plot of ORs/CIs) → matplotlib figure output.
"Draft LaTeX review section on Taiwan genotyping trial with citations and incidence table"
Synthesis Agent → gap detection → Writing Agent → latexEditText (review text) → latexSyncCitations (Ko et al., 2015) → latexCompile → PDF with table.
"Find GitHub repos analyzing HLA-B*58:01 genotyping data from these papers"
Research Agent → paperExtractUrls (Nguyen et al., 2016) → paperFindGithubRepo → Code Discovery → githubRepoInspect → validated analysis scripts.
Automated Workflows
Deep Research workflow scans 50+ papers via citationGraph from Ko et al. (2015), structures SCAR incidence report with GRADE scores. DeepScan applies 7-step verification: searchPapers → readPaperContent → runPythonAnalysis on Wu et al. (2016) meta-data → CoVe checkpoints. Theorizer generates hypotheses on HLA-B*58:01 mechanisms from Verma et al. (2013) and Jurado-Escobar et al. (2017).
Frequently Asked Questions
What defines HLA-B*58:01 association with allopurinol hypersensitivity?
HLA-B*58:01 allele confers high risk for SCARs like SJS/TEN upon allopurinol exposure, with odds ratios >100 in Asians (Wu et al., 2016).
What methods prove this association?
Prospective genotyping (Ko et al., 2015) reduced SCARs to 0%; meta-analysis of 21 studies confirmed (Wu et al., 2016); rapid PCR validation (Nguyen et al., 2016).
What are key papers?
Ko et al. (2015, BMJ, 197 citations) Taiwan cohort; Ke et al. (2017, 61 citations) cost-effectiveness; Wu et al. (2016, 39 citations) meta-analysis.
What open problems remain?
Validation in non-Asians, adherence to alternatives, and workflow integration in low-resource settings (Duc et al., 2020; Jurado-Escobar et al., 2017).
Research Drug-Induced Adverse Reactions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HLA-B*5801 Association with Allopurinol Hypersensitivity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Drug-Induced Adverse Reactions Research Guide